Bioresorbable vascular scaffold for the treatment of coronary in-stent restenosis: New dawn or frost on snow?

Jun-Bo Ge

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)

BVS might be non-inferiority compared to DES or DEB in ISR treatment in terms of 1-year DOCE. BVS, especially thinner-strut stent may be an attractive alternative in ISR setting. Large prospective randomized trials are needed to provide convince evidences to direct clinical practice in the future.

Keyphrases

clinical practice
coronary artery
combination therapy
current status
left ventricular
aortic valve
smoking cessation
ejection fraction